Consider the proven safety profile of the WATCHMAN device

Consider the Proven Safety Profile of the WATCHMANTM Device

WATCHMAN maintains favorable safety outcomes in real-life studies

The EWOLUTION Prospective Registry showed a 98,5% implant success rate
the highest success rate reported in all WATCHMAN trials1.

* Implant success defined as deployment and release of the device into the LAA; no leak ≥ 5 mm 

Low complication rates demonstrated in clinical trials

The EWOLUTION Prospective Registry showed a 2,8% peri-procedural risk rate – the lowest peri-procedural risk rate reported in all WATCHMAN trials1.

** Serious Adverse Event - Composite fo vascular complications includes cardia perforation, pericardial effusion with tamponade, ischemic stroke, device embolization, and other vascular complications.

Learn more about the EWOLUTION registry

EWOLUTION (Registry on WATCHMANTM Outcomes in Real-Life Utilization) is the largest prospective real-life LAAC registry with over 1.000 patients studied. The EWOLUTION registry is a multicentre study designed to obtain clinical data on procedural success, complication rates, incidence of stroke, bleeding, and long-term patient outcomes.

Learn more about the WATCHMAN Clinical Programme

See WATCHMAN safety and efficacy papers

References
* Implant success defined as deployment and release of the device into the LAA; no leak ≥ 5 mm 
1. Boersma LVA et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J 2016;37(31):2465-74. 

CAUTION: The law restricts these devices to sale by our on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device.
Information for the use only in countries with applicable health authority product registrations. Information contained herein is for distribution outside the U.S., Japan and France.